SLT Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.1M Sell
950
-15
-2% -$17.7K 0.64% 41
2026
Q2
$1.16M Buy
965
+438
+83% +$448K 0.71% 38
2026
Q1
$485K Buy
527
+106
+25% +$107K 0.33% 70
2025
Q4
$452K Buy
421
+146
+53% +$140K 0.29% 82
2025
Q3
$210K Sell
275
-1
-0.4% -$744 0.14% 119
2025
Q2
$215K Hold
276
– – 0.16% 93
2025
Q1
$228K Buy
+276
New +$230K 0.21% 68

Other funds holding LLY

SLT Holdings's LLY Position: Q3 2026 in Review

SLT Holdings reduced its Eli Lilly (LLY) stake by 1.6% in Q3 2026, selling an estimated $17.7K and leaving 950 shares worth $1.1M. The position accounts for 0.64% of the portfolio, ranked #41.

SLT Holdings first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.16M in Q2 2026. 2,688 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • SLT Holdings held 950 shares of Eli Lilly worth $1.1M as of Q3 2026.
  • SLT Holdings sold 15 Eli Lilly shares in Q3 2026, an estimated $17.7K.
  • Eli Lilly made up 0.64% of SLT Holdings's portfolio in Q3 2026, its #41 holding.
  • SLT Holdings first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
  • SLT Holdings's Eli Lilly position peaked at $1.16M in Q2 2026.
  • 2,688 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on SLT Holdings's 13F filing for Q3 2026, filed 15 Oct 2026.